We fund type 1 diabetes research to improve lives and one day eradicate the condition for good.

Your support makes this happen.

Donate now

Join the 100 Challenge

Mark 100 years of insulin by taking on a sporty 100 challenge for World Diabetes Day. Help support our latest research into prevention, treatment & cure.

Sign up today

Latest news and events

Research progress: immunotherapy teplizumab can delay type 1 diabetes for three years

Teplizumab, the ground-breaking immunotherapy underpinned by JDRF research, can delay type 1 diabetes by an average of nearly three years.

Read more

First drug to delay type 1 diabetes receives approval from key US advisory committee

The first drug to delay type 1 diabetes in those at risk is approved by key US advisory committee. The drug - underpinned by JDRF research - could also lead to cures for those already with the condition.

Read more

NPDA: "Dire" inequality among children with type 1 diabetes on access to technology

Children in England and Wales face stark inequalities in type 1 diabetes care, according to the National Paediatric Diabetes Audit (NPDA).

Read more

Hybrid closed loop technology for type 1 diabetes could be available on the NHS by 2022

The National Institute for Health and Care Excellence (NICE) has confirmed that it will be appraising hybrid closed loop technology for type 1 diabetes.

Read more

New £1.3m grant call provides significant boost to autoimmune research

Pioneering partnership brings significant new investment to confront the UK’s high prevalence of autoimmune conditions.  

Read more

You may also be interested in

Buy JDRF merchandise online

Show your support for type 1 diabetes research - shop face masks, clothing, Rufus the Bear and virtual gifts today

Shop online now

Play the JDRF lottery

JDRF’s weekly lottery gives you the chance to win a fantastic £25,000 for just £1 per entry!

Play now!

Type 1 Discovery magazine out now!

Download issue 88 for research news, features, updates, interviews and much more

Read now